Molecule Holdings Operating Income

Molecule Holdings (ERV2.F) currently reports a operating income of $-2.4M as of July 2023. That compares with $-3.6M in the prior-year period — up 33.0% year over year. Use the charts on this page to explore Molecule Holdings's operating income history and peer comparisons.

Molecule Holdings's operating income increased from $-3.6M to $-2.4M — a 33.0% year-over-year increase (period ending July 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Molecule Holdings reported $-2.4M in operating income as of July 2023. That compares with $-3.6M in the prior-year period — up 33.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-2.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Molecule Holdings, and consider following ERV2.F for alerts when major investors trade the stock.